Literature DB >> 8666153

Adipose tissue leptin production and plasma leptin kinetics in humans.

S Klein1, S W Coppack, V Mohamed-Ali, M Landt.   

Abstract

Abdominal adipose tissue leptin production was determined in vivo by arteriovenous balance in 14 lean and obese men (mean BMI 27.0 +/- 1.9, range 21.4-45.2). Blood samples were taken simultaneously from an abdominal vein that drains subcutaneous adipose tissue and from a radial artery. Adipose tissue blood flow was measured by xenon washout. Abdominal vein leptin concentrations (mean 8.9 +/- 2.4 ng/ml, range 2.1-36.5 ng/ml) were consistently greater than arterial values (mean 6.6 +/- 1.9 ng/ml, range 1.7-28.2 ng/ml) (P < 0.001). The net rate of abdominal adipose tissue leptin production (mean 3.2 +/- 0.5 ng x 100 g(-1) x min(-1)) correlated directly with percentage body fat (rs = 0.59, P = 0.016). Estimated whole-body leptin production rate (797 +/- 283 ng x person(-1) x min(-1)) correlated directly with percent body fat (rs = 0.93, P < 0.0001) and with regional leptin production (rs = 0.81, P < 0.001). In contrast, the rate of leptin clearance from plasma (mean 1.50 +/- 0.23 ml x kg(-1) x min(-1)) and plasma leptin half-life (mean 24.9 +/- 4.4 min) was unrelated to adiposity (rs = 0.06, P = 0.30; rs = 0.16, P = 0.30, respectively). These results provide direct evidence that leptin is produced by adipose tissue in humans and that the rate of production is directly related to adiposity. A combination of greater leptin production per unit of body fat and increased production from expanded total body fat mass, rather than alterations in leptin clearance, account for the increase in plasma leptin concentrations observed in obese humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666153     DOI: 10.2337/diab.45.7.984

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  59 in total

1.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; J W Kolaczynski; M Polansky
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Association between Serum Thyroid-Stimulating Hormone Levels and Visceral Adipose Tissue: A Population-Based Study in Northeast Germany.

Authors:  Tilman Witte; Henry Völzke; Markus M Lerch; Katrin Hegenscheid; Nele Friedrich; Till Ittermann; John A Batsis
Journal:  Eur Thyroid J       Date:  2016-11-08

4.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

5.  In vivo microdialysis sampling of adipokines CCL2, IL-6, and leptin in the mammary fat pad of adult female rats.

Authors:  Geetika Bajpai; Rosalia C M Simmen; Julie A Stenken
Journal:  Mol Biosyst       Date:  2014-01-24

Review 6.  Regulation of circulating leptin in humans.

Authors:  B Ahrén; H Larsson; C Wilhelmsson; B Näsman; T Olsson
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

7.  Presence of bovine leptin in edible commercial milk and infant formula.

Authors:  M Lage; R Baldelli; J P Camiña; J Rodriguez-Garci; A Peñalva; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

8.  Effects of a weight-reduction program with orlistat on serum leptin levels in obese women: A 12-week, randomized, placebo-controlled study.

Authors:  Oguz Ozcelik; Halil Dogan; Haluk Kelestimur
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

Review 9.  Leptin and obesity in humans.

Authors:  R V Considine
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

10.  C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth.

Authors:  Jennifer Staiger; Mary J Lueben; David Berrigan; Radek Malik; Susan N Perkins; Stephen D Hursting; Peter F Johnson
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.